CAPG and breast cancer: Furthermore, we queried the Kaplan-Meier Plotter breast cancer database and found that, in breast cancer patients received systemic chemotherapy, patients with high CapG expression exhibited significantly decreased RFS interval than those with low CapG expression (P=0.0055, HR=1.25; 95% CI, 1.07-1.46) (Figure 1F).